BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33314567)

  • 1. RAD51AP1 promotes progression of ovarian cancer via TGF-β/Smad signalling pathway.
    Zhao H; Gao Y; Chen Q; Li J; Ren M; Zhao X; Yue W
    J Cell Mol Med; 2021 Feb; 25(4):1927-1938. PubMed ID: 33314567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers.
    Chudasama D; Bo V; Hall M; Anikin V; Jeyaneethi J; Gregory J; Pados G; Tucker A; Harvey A; Pink R; Karteris E
    Carcinogenesis; 2018 Mar; 39(3):407-417. PubMed ID: 29126163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive bioinformatics analysis confirms RBMS3 as the central candidate biological target for ovarian cancer.
    Wang M; Fu X; Wang W; Zhang Y; Jiang Z; Gu Y; Chu M; Shao Y; Li S
    Med Eng Phys; 2022 Dec; 110():103883. PubMed ID: 36075788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.
    Sun W; Gui L; Zuo X; Zhang L; Zhou D; Duan X; Ren W; Xu G
    J Transl Med; 2016 Mar; 14():75. PubMed ID: 26983758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
    Zuo L; Li X; Tan Y; Zhu H; Xiao M
    J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
    Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
    J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas.
    Wang Q; Tan Y; Fang C; Zhou J; Wang Y; Zhao K; Jin W; Wu Y; Liu X; Liu X; Kang C
    Aging (Albany NY); 2019 Sep; 11(18):7707-7722. PubMed ID: 31532757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FUBP1 mediates the growth and metastasis through TGFβ/Smad signaling in pancreatic adenocarcinoma.
    Zhang Y; Chen J; Zhou N; Lu Y; Lu J; Xing X; Chen H; Zhang X
    Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33649780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
    Baldwin RL; Tran H; Karlan BY
    Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway.
    Guo Y; Cui W; Pei Y; Xu D
    Gynecol Oncol; 2019 Jun; 153(3):639-650. PubMed ID: 30928020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of RAD51AP1 suppresses epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Wu Y; Wang H; Qiao L; Jin X; Dong H; Wang Y
    Thorac Cancer; 2019 Sep; 10(9):1748-1763. PubMed ID: 31317661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of SPINK13 Promotes Metastasis by Regulating uPA in Ovarian Cancer Cells.
    Cai S; Zhang P; Dong S; Li L; Cai J; Xu M
    Cell Physiol Biochem; 2018; 45(3):1061-1071. PubMed ID: 29439245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Expression of
    Zou R; Xu H; Li F; Wang S; Zhu L
    DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling.
    Xu M; He J; Li J; Feng W; Zhou H; Wei H; Zhou M; Lu Y; Zeng J; Peng W; Du F; Gong A
    Br J Cancer; 2017 Jan; 116(1):91-99. PubMed ID: 27898661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
    Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer.
    Cheng Z; Guo J; Chen L; Luo N; Yang W; Qu X
    Oncotarget; 2015 Sep; 6(28):25381-9. PubMed ID: 26299803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer.
    Zhang P; Su T; Zhang S
    J Immunol Res; 2021; 2021():5574176. PubMed ID: 34189143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.